483
National Institutes of Health IRBNational Institutes of Health IRB – FDA 483, Oct 11, 2023
Record Details
An FDA inspection of the National Institutes of Health IRB in Bethesda, MD, revealed that for non-expedited reviews, research approved by the IRB did not consistently receive the required majority approval from members present. This was specifically due to a lack of quorum during several meetings between July and September 2023, where an insufficient number of primary members voted on FDA-regulated studies.
View Company Profile
ID · d70ab36d-7d76-4749-8fbf-400212346bfa
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.